vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and SITIME Corp (SITM). Click either name above to swap in a different company.
SITIME Corp is the larger business by last-quarter revenue ($113.3M vs $85.1M, roughly 1.3× 4D Molecular Therapeutics, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 8.1%, a 14.7% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 66.3%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $13.0M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 85.2%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
SiTime Corporation is a publicly traded fabless chipmaker based in Santa Clara, California that develops micro-electromechanical systems (MEMS), used for timing devices in electronics.
FDMT vs SITM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $113.3M |
| Net Profit | $19.4M | $9.2M |
| Gross Margin | — | 56.4% |
| Operating Margin | 17.3% | 1.6% |
| Net Margin | 22.8% | 8.1% |
| Revenue YoY | 8508900.0% | 66.3% |
| Net Profit YoY | 139.1% | 148.7% |
| EPS (diluted) | $0.43 | $0.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $113.3M | ||
| Q3 25 | $90.0K | $83.6M | ||
| Q2 25 | $15.0K | $69.5M | ||
| Q1 25 | $14.0K | $60.3M | ||
| Q4 24 | $1.0K | $68.1M | ||
| Q3 24 | $3.0K | $57.7M | ||
| Q2 24 | $5.0K | $43.9M | ||
| Q1 24 | $28.0K | $33.0M |
| Q4 25 | $19.4M | $9.2M | ||
| Q3 25 | $-56.9M | $-8.0M | ||
| Q2 25 | $-54.7M | $-20.2M | ||
| Q1 25 | $-48.0M | $-23.9M | ||
| Q4 24 | — | $-18.8M | ||
| Q3 24 | $-43.8M | $-19.3M | ||
| Q2 24 | $-35.0M | $-26.8M | ||
| Q1 24 | $-32.4M | $-28.7M |
| Q4 25 | — | 56.4% | ||
| Q3 25 | — | 53.5% | ||
| Q2 25 | — | 51.9% | ||
| Q1 25 | — | 50.3% | ||
| Q4 24 | — | 52.6% | ||
| Q3 24 | — | 51.1% | ||
| Q2 24 | — | 49.1% | ||
| Q1 24 | — | 53.5% |
| Q4 25 | 17.3% | 1.6% | ||
| Q3 25 | -67983.3% | -19.2% | ||
| Q2 25 | -396373.3% | -35.4% | ||
| Q1 25 | -383007.1% | -46.6% | ||
| Q4 24 | — | -33.8% | ||
| Q3 24 | -1704400.0% | -43.1% | ||
| Q2 24 | -849120.0% | -73.7% | ||
| Q1 24 | -136200.0% | -106.1% |
| Q4 25 | 22.8% | 8.1% | ||
| Q3 25 | -63195.6% | -9.6% | ||
| Q2 25 | -364386.7% | -29.0% | ||
| Q1 25 | -342657.1% | -39.6% | ||
| Q4 24 | — | -27.6% | ||
| Q3 24 | -1461433.3% | -33.5% | ||
| Q2 24 | -699060.0% | -61.0% | ||
| Q1 24 | -115717.9% | -86.9% |
| Q4 25 | $0.43 | $0.44 | ||
| Q3 25 | $-1.01 | $-0.31 | ||
| Q2 25 | $-0.98 | $-0.84 | ||
| Q1 25 | $-0.86 | $-1.01 | ||
| Q4 24 | — | $-0.80 | ||
| Q3 24 | $-0.79 | $-0.83 | ||
| Q2 24 | $-0.63 | $-1.16 | ||
| Q1 24 | $-0.66 | $-1.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $505.7M | $1.2B |
| Total Assets | $566.7M | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | — | ||
| Q3 25 | $305.1M | — | ||
| Q2 25 | $293.2M | — | ||
| Q1 25 | $321.4M | — | ||
| Q4 24 | $424.9M | — | ||
| Q3 24 | $501.9M | — | ||
| Q2 24 | $541.9M | — | ||
| Q1 24 | $525.9M | — |
| Q4 25 | $505.7M | $1.2B | ||
| Q3 25 | $369.0M | $1.1B | ||
| Q2 25 | $420.9M | $1.1B | ||
| Q1 25 | $469.7M | $692.5M | ||
| Q4 24 | $510.6M | $699.7M | ||
| Q3 24 | $552.9M | $696.2M | ||
| Q2 24 | $588.3M | $692.5M | ||
| Q1 24 | $600.6M | $696.2M |
| Q4 25 | $566.7M | $1.3B | ||
| Q3 25 | $424.0M | $1.3B | ||
| Q2 25 | $473.6M | $1.3B | ||
| Q1 25 | $515.7M | $872.1M | ||
| Q4 24 | $560.4M | $885.0M | ||
| Q3 24 | $604.0M | $877.9M | ||
| Q2 24 | $620.1M | $878.6M | ||
| Q1 24 | $629.9M | $942.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $25.4M |
| Free Cash FlowOCF − Capex | $28.5M | $13.0M |
| FCF MarginFCF / Revenue | 33.5% | 11.5% |
| Capex IntensityCapex / Revenue | 0.1% | 10.9% |
| Cash ConversionOCF / Net Profit | 1.47× | 2.77× |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $35.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $25.4M | ||
| Q3 25 | $-46.5M | $31.4M | ||
| Q2 25 | $-43.4M | $15.3M | ||
| Q1 25 | $-47.8M | $15.0M | ||
| Q4 24 | $-134.6M | $13.5M | ||
| Q3 24 | $-29.4M | $8.2M | ||
| Q2 24 | $-30.2M | $-181.0K | ||
| Q1 24 | $-29.1M | $1.7M |
| Q4 25 | $28.5M | $13.0M | ||
| Q3 25 | $-46.6M | $26.3M | ||
| Q2 25 | $-43.4M | $-2.9M | ||
| Q1 25 | $-48.4M | $-1.3M | ||
| Q4 24 | $-138.4M | $-2.4M | ||
| Q3 24 | $-31.2M | $-6.7M | ||
| Q2 24 | $-30.6M | $-2.7M | ||
| Q1 24 | $-29.8M | $-1.2M |
| Q4 25 | 33.5% | 11.5% | ||
| Q3 25 | -51765.6% | 31.5% | ||
| Q2 25 | -289620.0% | -4.2% | ||
| Q1 25 | -345635.7% | -2.1% | ||
| Q4 24 | -13837100.0% | -3.5% | ||
| Q3 24 | -1038966.7% | -11.6% | ||
| Q2 24 | -611840.0% | -6.3% | ||
| Q1 24 | -106421.4% | -3.6% |
| Q4 25 | 0.1% | 10.9% | ||
| Q3 25 | 101.1% | 6.1% | ||
| Q2 25 | 440.0% | 26.2% | ||
| Q1 25 | 4507.1% | 27.0% | ||
| Q4 24 | 378600.0% | 23.3% | ||
| Q3 24 | 59266.7% | 25.7% | ||
| Q2 24 | 6980.0% | 5.8% | ||
| Q1 24 | 2535.7% | 8.8% |
| Q4 25 | 1.47× | 2.77× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
